0.700
-0.02 (-2.51%)
| Previous Close | 0.718 |
| Open | 0.720 |
| Volume | 48,434 |
| Avg. Volume (3M) | 74,993 |
| Market Cap | 49,442,712 |
| Price / Earnings (TTM) | 70.00 |
| Price / Sales | 0.810 |
| Price / Book | 2.84 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Profit Margin | 5.99% |
| Operating Margin (TTM) | 1.75% |
| Diluted EPS (TTM) | 0.050 |
| Quarterly Revenue Growth (YOY) | 48.20% |
| Quarterly Earnings Growth (YOY) | -91.00% |
| Total Debt/Equity (MRQ) | 148.83% |
| Current Ratio (MRQ) | 1.09 |
| Operating Cash Flow (TTM) | -1.40 M |
| Levered Free Cash Flow (TTM) | -5.71 M |
| Return on Assets (TTM) | 5.60% |
| Return on Equity (TTM) | 26.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Mixed | Bearish |
| Household & Personal Products (Global) | Mixed | Bearish | |
| Stock | Solesence, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | -1.13 |
|
Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Small Core |
| % Held by Insiders | 73.51% |
| % Held by Institutions | 0.96% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |